Ocugen to resume Covaxin trials ‘immediately’ after FDA lifts its latest clinical hold

The hold was put in place as a result of statements made by the World Health Organization after its inspection of Bharat Biotech’s manufacturing facility.
Click here to view original post

Be the first to comment

Leave a Reply

Your email address will not be published.